Presentation on Beximco Pharmaceuticals Name of the presenters ~ Faisal Bin Kamal 2009-3-10-057 2010-1-10-145 2010-1-10-149 2010-1-40-052 ~ Quazi Aritra Reyan ~ Md. Nayeem Hossain ~ Tahrim Shahriar Background of the Company Beximco Pharmaceuticals (BPL) is a leading edge pharmaceutical company based in Dhaka‚ Bangladesh. BPL started its operation in 1980 and now have grown to become nation’s one of the leading pharmaceutical companies. ~ BPL supplies more than 10% of country’s
Premium Pharmaceutical industry Tax Balance sheet
Mr. Kirk Bowman ，a successful attorney and entrepreneur，made a presentation to share his experiences and offer advice on succeeding as an entrepreneur in the global market. In the presentation‚ Mr. Bowman first share his philosophy of life ‚ about what ‚how ‚why and the things good at ‚like ‚make money ‚mentioned Simon Sinek with his book “how great leaders inspire action” ‚GUY KAWASAKI and his book ”The Art of Changing Hearts ‚Minds ‚and Actions”‚ a nonprofit devoted to Ideas Worth Spreading named
Premium Marketing
There is a lot of discussion about pharmaceutical companies‚ intellectual property‚ and the global AIDS epidemic. Do pharmaceutical companies have a responsibility to distribute drugs for free or low cost in developing countries? Why is intellectual property such a big deal? What impact would South Africa’s decision to levy duties on drugs in the country have on the international distribution of drugs? Was the change that provided patent protection for pharmaceutical companies an appropriate change
Premium Generic drug Developing country Developed country
GBUS 450 Case Study 3: Developing a Sourcing Strategy at Medwell Pharmaceutical Corporation Case Background Medwell Pharmaceutical Corporation (MPC)‚ Inc. is a medium-sized (but growing) pharmaceutical company located in central New Jersey. The company’s new drugRegenerix has recently been approved for commercialization by FDA. MPC knows it must manage its product launch quickly and effectively‚ in order to occupy the market. As a result of an earlier study
Premium Process control
Emily Bowman- Emily has been my best friend all throughout high school. We have been through so much together and I don’t know what either of us would do without the other one. I would say one of my favorite memories with Emily is probably driving around town and driving through the graveyard on Beck Road. I remember we pulled in and as I kept going we swore we weren’t scared and then the road turned into gravel and the exit gate was locked so we had to do a U-turn in the middle of the graveyard
Premium Family English-language films Debut albums
Teva Pharmaceutical Industries‚ Ltd 1) External Environment: The Pharmaceutical Industry is dependent on political and legal conditions of general environment. In pharmaceutical industry we have two kind of medications which are generic or innovative. Innovative pharmaceutical industry success depends on the patent protection in the industry. For example‚ in United States innovative industry can have 10 to 12 years of patent protection life from the time that product is for sale in the
Premium Generic drug Pharmaceutical industry Food and Drug Administration
Ethics of the Relationship Between Physicians and the Pharmaceutical Industry Dr. Pankaj Gupta Dr. Aaditya Udupa The pharmaceutical industry‚ the medical profession and the patient have a unique‚ symbiotic relationship. The industry makes products which it cannot sell to the patient (consumer) directly. On the other hand‚ the medical profession cannot treat the patient without drugs produced by the industry. Thus‚ the industry and medical profession are interdependent with a
Premium Physician Medicine Pharmacology
Counterfeit Drugs Problems and Solutions for the Indian Pharmaceutical Industry Introduction Counterfeit drugs have been around for much of the recent history of industrial-scale drug production in India and abroad. Although detailed data on counterfeit medicines are difficult to obtain by virtue of its very nature‚ a recent WHO report estimates the prevalence to be around 1% of sales in developed countries to over 10% in some developing countries1. The more important aspect of this global
Premium Pharmaceutical industry Authentication Pharmacology
Industry Surveys Autos & Auto Parts Efraim Levy‚ CFA‚ Auto Manufacturers & Auto Parts Equity Analyst JULY 2014 Current Environment ............................................................................................ 1 Industry Profile .................................................................................................... 10 Industry Trends ................................................................................................... 12 How the Industry Operates ......
Premium Automotive industry General Motors Automobile
OVERVIEW – INDIAN PHARMACEUTICALINDUSTRY | | 1.1 | Current Scenario | 6 | 1.2 | Major Pharmaceutical Companies | 10 | 1.3 | Government Initiatives | 12 | 1.4 | Oncology Segment | 15 | | LUNG CANCER | | 2.1 | World Scenario | 21 | 2.2 | Indian Scenario | 22 | 2.3 | About Lung Cancer | 30 | 2.4 | Stages of Lung Cancer | 36 | 2.5 | Causes of Lung Cancer | 46 | | LONG LIFE PHARMACEUTICALS PVT. LTD. | | 3.1 | Vision and Mission | 48 | 3.2 | Board of Directors | 49 | 3.3
Premium Cancer Lung cancer Oncology